homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

February 14, 2019

Omeros

Seattle biopharmaceutical company Omeros appointed Dr. Thomas F. Bumol to its board. Bumol is executive director of Allen Institute for Immunology and a former senior executive at Eli Lilly and Co.




Email or user name:
Password:
 
Forgot password? Click here.